Bleeding Complications Following Image-Guided Kidney Biopsy: A Single-Center Experience
Purpose Compare clinically significant bleeding rates across native, transplant, and renal mass image-guided biopsies; characterize bleeding timing to guide post-procedure monitoring; and identify associated patient and procedural factors. Methods A radiology information system search identified all image-guided renal biopsies by the abdominal imaging section from 01/01/2021 to 04/01/2025. Data included demographics, laboratory values, procedural parameters, and intra- and post-procedure bleeding findings. Clinically significant bleeding was defined by post-procedure CT showing active extravasation or moderate/large hematoma, or intervention to control bleeding. Results The cohort comprised 1,255 biopsies (508 native, 615 transplant, 132 renal mass), with clinically significant bleeding in 45 (3.6%). Native kidneys bled nearly three times more often than transplants (5.7% [29/508] vs. 2.0% [12/615]; OR, 3.04; p = .001) and required more interventions (4.1% [21/508] vs. 0.8% [5/615]; p < .001); the renal mass rate (3.0% [4/132]) did not differ significantly from either. Detection was temporally distributed: 42.2% of events occurred within 2 hours, 8.9% between 2–6 hours, 24.4% between 6–24 hours, and 24.4% beyond 24 hours. On multivariable analysis of pre-procedural factors, biopsy target (p = .02), platelet count (p = .003), and systolic blood pressure (p = .04) independently predicted bleeding; female sex showed a borderline association (p = .051). Conclusion Higher bleeding risk of native over transplant biopsy persisted after adjustment for baseline patient factors. Bleeding events clustered within 2 hours (42%) or beyond 24 hours (24%), and most events detected after leaving the biopsy suite were prompted by patient-reportable rather than monitoring-dependent symptoms.
Authors
- Malak Itani (ORCID: https://orcid.org/0000-0002-8964-6400)
- Daniel Ludwig
- Annika Agrawal (ORCID: https://orcid.org/0009-0001-4472-7055)
- Julia B. Huecker
- Sam Meiselman (ORCID: https://orcid.org/0009-0006-9612-5570)
- Benjamin Strnad
Institutions
- Washington University in St. Louis (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-11577101/v1
- Primary Topic
- Renal and Vascular Pathologies
- Type
- preprint
Funders
- Institute of Clinical and Translational Sciences
- Alvin J. Siteman Cancer Center
- National Institutes of Health
- National Cancer Institute
- National Center for Advancing Translational Sciences